Another study also showed that among patients with anti-MDA5+ DM, the mortality rate was significantly higher among those with than without RP-ILD, most patients died within 6 months of developing symptoms, and the 6-month survival rate was only 41% (14). The gene discussed is IFIH1; the disease is interstitial lung disease.